mk 0591 has been researched along with thromboxane b2 in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
De Lepeleire, I; De Schepper, PJ; Depré, M; Larson, P; Lin, C; Porras, A; Schwartz, J; Van Hecken, A; Verbesselt, R | 1 |
Akiyama, K; Ishii, T; Mita, H | 1 |
1 trial(s) available for mk 0591 and thromboxane b2
Article | Year |
---|---|
Pharmacokinetic and pharmacodynamic interaction between the lipoxygenase inhibitor MK-0591 and the cyclooxygenase inhibitor ibuprofen in man.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Cyclooxygenase Inhibitors; Digestive System; Double-Blind Method; Drug Interactions; Drug Tolerance; Humans; Ibuprofen; Indoles; Kidney; Leukotriene B4; Leukotriene E4; Lipoxygenase Inhibitors; Male; Quinolines; Thromboxane B2 | 1998 |
1 other study(ies) available for mk 0591 and thromboxane b2
Article | Year |
---|---|
Generation of thromboxane A2 from highly purified human sinus mast cells after immunological stimulation.
Topics: 5-Lipoxygenase-Activating Proteins; Alternative Splicing; Antibodies, Anti-Idiotypic; Carrier Proteins; Cell Separation; Dose-Response Relationship, Drug; Histamine Release; Humans; Indoles; Mast Cells; Membrane Proteins; Methacrylates; Nasal Mucosa; Paranasal Sinuses; Prostaglandin D2; Quinolines; RNA, Messenger; Thromboxane A2; Thromboxane B2; Thromboxane-A Synthase | 1999 |